Dr. Frank Brown of Accelrys Named to Board of Directors of BioIT Alliance

SAN DIEGO, CA--(Marketwire - August 18, 2009) - Accelrys, Inc. (NASDAQ: ACCL), a leading
provider of scientific business intelligence software and services, today
announced that Dr. Frank Brown, senior vice president and chief science
officer of Accelrys,
has been appointed to the board of directors of the BioIT Alliance, a group of
organizations working together to realize the potential of personalized
medicine. Accelrys is one of the founding members of the alliance.

Appointed by the BioIT Alliance, Dr. Brown will join an elite group of
industry leaders in his new position.

"The appointment of Dr. Brown to the BioIT Alliance board of directors is
due to his passion for scientific informatics and addressing the challenges
that life sciences companies face in the areas of research, discovery and
development," said Les Jordan, director of the BioIT Alliance and industry
technology strategist for Life Sciences at Microsoft. "He will undoubtedly
bring strong, reasoned leadership to this new role, and his guidance will
help lead the BioIT Alliance further in its mission to drive integration
between technologies, develop standards and foster collaboration."

The BioIT Alliance unites the healthcare IT, pharmaceutical, biotech,
hardware and software industries to explore new ways to share complex
biomedical data and collaborate among multi-disciplinary teams to speed the
pace of discovery. Life Science companies have unique technical challenges
in data integration, collaboration, and knowledge management that cannot be
solved by any organization alone. The BioIT Alliance brings together
science, health and technology leaders to consider innovative ways to
address these challenges and use technology to reduce costs, streamline
research, and market their products more effectively.

"I'm delighted to be appointed to the BioIT Alliance board. This is an
exciting opportunity to help lead conversations about some of the most
important issues confronting the life sciences industry," said Brown. "If
personalized medicine is to become a reality, it is more important than
ever to deliver information technologies which increase the success rate of
discovering and developing New Chemical Entities (NCEs) and to design
strategies for the most effective application of these NCEs to the health
care system."

About BioIT Alliance

Formed in 2006, the BioIT Alliance is a cross-industry group working to
integrate science and technology in order to accelerate the pace of drug
discovery and realize the potential of personalized medicine. Founding
members include Accelrys Software Inc., Affymetrix, Inc., Agilent
Technologies Inc., Amylin Pharmaceuticals, Inc., Applied Biosystems, The
BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corporation,
Geospiza Inc., Hewlett-Packard Development Company, L.P., Illumina Inc.,
InterKnowlogy, Microsoft Corporation, Sun Microsystems Inc., The Scripps
Research Institute, VizX Labs LLC and other key companies in the
pharmaceutical, biotech, hardware and software industries. Additional
information about the BioIT Alliance can be found on the BioIT Alliance Web
site at http://www.bioitalliance.org

About Accelrys, Inc.

Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and
solutions for the life sciences, energy, chemicals, aerospace, and consumer
products industries. Customers include many
Fortune 500 companies and other commercial entities, as well as academic
and government entities. Accelrys has a vast portfolio of computer-aided
design modeling and simulation offerings which assist customers in
conducting scientific experiments 'in silico' in order to reduce the
duration and cost of discovering and developing new drugs and materials.
Its scientific business
intelligence platform underlies the company's computer-aided design
modeling and simulation offerings. The Accelrys platform can be used with
both Accelrys and competitive products, as well as with customers'
proprietary predictive science products. Its flexibility, ease-of-use and
advanced chemical, text and image analysis and reporting capabilities
enable customers to mine, aggregate, analyze and report scientific data
from disparate sources, thereby better utilizing scientific data within
their organizations. For more information about Accelrys, visit
http://accelrys.com/